A practical reference on Semax: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-07-13. Anything still debated is marked as such rather than presented as settled.
The proposed mechanism centres on neurotrophic signalling rather than direct receptor activation. Semax is reported to increase expression of brain-derived neurotrophic factor and nerve growth factor in several brain regions, and to shift the balance between excitatory and inhibitory neurotransmitter systems. Interaction with melanocortin receptors has been suggested because of the parent ACTH fragment. Many of these findings come from rodent studies, and the extent to which they translate to human physiology remains an open question.
Scientific literature on semax is unevenly distributed. A substantial share of published work originates from a small number of laboratories in Russia, while independent replication elsewhere is limited. Human data consist mostly of small trials with short follow-up, and several reported outcomes rely on subjective rating scales. Questions about how much intact peptide reaches the central nervous system after nasal administration, and how long it persists there, are still unresolved. The compound is best described as an active research subject rather than a settled pharmacological agent.
Regulatory status differs sharply between jurisdictions. In Russia the peptide is registered as a prescription nasal preparation, while agencies such as the United States Food and Drug Administration have not approved it for any indication. Products sold elsewhere are typically labeled for laboratory research only, and such labels shift responsibility for safe handling to the purchaser. Because the same name covers pharmaceutical-grade nasal drops and bulk research powder, identity and purity documentation becomes the main practical concern when comparing sources.
Semax is a synthetic seven-amino-acid peptide whose sequence extends the ACTH(4-10) fragment with a C-terminal proline-glycine-proline tripeptide. The commonly cited sequence is Met-Glu-His-Phe-Pro-Gly-Pro, giving a molecular formula near C37H51N9O10S and a molecular weight close to 813.9 g/mol. It belongs to the broader class of synthetic ACTH fragments studied for central nervous system effects rather than for adrenal steroid stimulation. In practice the material appears as a lyophilized white powder for laboratory work or as a dilute saline solution in clinical settings.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C37H51N9O10S | Calculated for the free peptide |
| Molar mass | 813.9 g/mol | Anhydrous free base |
| Peptide class | Synthetic heptapeptide | ACTH(4-10) analogue |
| Parent fragment | ACTH(4-10) | Adrenocorticotropic hormone segment |
| Developmental origin | Institute of Molecular Genetics, Moscow | Work began in the 1980s |
The C-terminal Pro-Gly-Pro extension is not incidental. Proline-rich tails are known to resist several common peptidases, and the published literature attributes the longer half-life of Semax, relative to unmodified ACTH fragments, to this feature. The modification also removes the melanocyte-stimulating and corticosteroidogenic activity that characterizes longer ACTH-derived sequences. Because the molecule is small and hydrophilic, it is typically formulated as an aqueous solution for intranasal or parenteral delivery. Acetylation or amidation at the termini appears in closely related research peptides and shifts the mass by a fixed increment.
Reported pharmacological work centers on neurotrophic signaling, including changes in BDNF and NGF expression in hippocampal tissue in animal models. Human data come largely from studies conducted in Russia, and how well those results generalize to other populations remains an open question. Regulatory status differs sharply by jurisdiction: Semax is a registered prescription medicine in Russia, while it holds no approved marketing status in the United States or the European Union. Outside such jurisdictions it is generally handled as a research chemical, which affects both documentation and quality expectations.
Regulatory status varies sharply by country. Semax is registered for medical use in Russia, where it appears in formularies as a nasal solution, and it also holds registration in a small number of neighbouring states. It has no approval from the United States Food and Drug Administration or the European Medicines Agency, and it is not a scheduled controlled substance in most jurisdictions. Elsewhere it circulates mainly as laboratory material, so purity documentation comes from suppliers rather than from a national pharmacopoeia.
Semax is a synthetic peptide created in the Soviet Union during the early 1980s by researchers working in Moscow. It was built from the short adrenocorticotropic hormone fragment known as ACTH(4-10), and the chain was then extended with three additional amino acids. The resulting molecule was named semax and entered clinical use in Russia in 1994. It is generally described as a nootropic and neuroprotective agent rather than as a hormone analogue.
Psychiatry is the medical specialty devoted to the diagnosis, treatment, and prevention of deleterious mental conditions. These include matters related to cognition, perceptions, mood, emotion, and behavior. Initial psychiatric assessment begins with taking a case history and conducting a mental status examination. Laboratory tests, physical examinations, and psychological assessments may also be used. On occasion, neuroimaging or neurophysiological studies are performed.
In response to US threats, Greenland's prime minister Jens-Frederik Nielsen said Trump would not "get" Greenland and that it is not for sale. The US threats have caused a pause in independence discussions, which Nielsen promoted during the previous elections. The PM stated that, "when faced with the choice between US and Denmark, Greenland chooses Denmark". A joint statement published by all parties in the Parliament of Greenland demanded that the US show respect and that they do not want to become part of the US, that they "do not want to be Americans." Greenland has moved to ban foreign political funding in response to US interference. 2025 and 2026 saw large demonstrations against the US in Greenland, with Greenlanders emphasising that "we are not for sale". Demonstrators carried placards bearing the slogans "no means no", "stop threatening us", and "Yankee go home!" On 12 January 2026, the government of Greenland issued a statement that they can "not under any circumstances" accept US demands for Greenland to become part of the US and that "Greenland is part of the Kingdom of Denmark", underlining the role of NATO in its defence. The government welcomed the initiative by six NATO members (reported to be the UK, Germany, France, Italy, Poland, and Spain) to increase NATO activity in Greenland.
==== Invariant principle ==== According to the Paccaya sutta (SN 12.20) and its parallel, this natural law of this/that conditionality is independent of being discovered by a Buddha (a "Tathāgata"), just like the laws of physics. The Paccaya sutta states that whether or not there are Buddhas who see it "this elemental fact (dhātu, or "principle") just stands (thitā), this basic-pattern-stability (dhamma-tthitatā), this basic-pattern-regularity (dhamma-niyāmatā): specific conditionality (idappaccayatā)." Bhikkhu Sujato translates the basic description of the stability of dependent origination as "the fact that this is real, not unreal, not otherwise". The Chinese parallel at SA 296 similarly states that dependent origination is "the constancy of dharmas, the certainty of dharmas, suchness of dharmas, no departure from the true, no difference from the true, actuality, truth, reality, non-confusion". According to Harvey, these passages indicate that conditionality is "a principle of causal regularity, a Basic Pattern (Dhamma) of things" which can be discovered, understood and then transcended.
== Function == According to Marvin et al. sHSPs independently express not only in heat shock response but also have developmental roles in embryonic or juvenile stages of mammals, teleost fish and some lower vertebral genomes. hspb1 (HSP27) is expressed during stress and during the development of embryo, somites, mid-hindbrain, heart and lens in zebrafish. Expression of the hspb4 gene, which codes for alpha crystallin, increases considerably in the lens in response to heat shock.
=== Symptomatic diagnostics === The diagnosis is aided by the presenting symptoms in any individual with an infectious disease, yet it usually needs additional diagnostic techniques to confirm the suspicion. Some signs are specifically characteristic and indicative of a disease and are called pathognomonic signs; but these are rare. Not all infections are symptomatic. In children the presence of cyanosis, rapid breathing, poor peripheral perfusion, or a petechial rash increases the risk of a serious infection by greater than 5 fold. Other important indicators include parental concern, clinical instinct, and temperature greater than 40 °C.
Sources: en.wikipedia.org
Ukrainian President Volodymyr Zelenskyy claimed that air defences had shot down some thirty six Shahed drones. In occupied Crimea, the regional governor said six Ukrainian drones were shot down. In an interview with Die Welt, Vadym Skibitsky, deputy head of Ukraine's military intelligence service, said the government intends to assassinate Putin "because he coordinates and decides what happens" in the war. Yevgeny Prigozhin announced the start of the turnover of Bakhmut from his Wagner mercenaries to the Russian military and his forces' withdrawal from the city. He also said they would repatriate the bodies of an American national, whom he identified as a former special forces soldier named Nicholas Maimer, and a Turkish citizen, which they claimed to have recovered from the remains of a building blown up by Ukrainian forces, adding that the body of another Turkish national, a woman, was also found but could not be retrieved. 106 Ukrainian POWs captured in Bakhmut were repatriated to Ukraine in a prisoner exchange with Russia. The FSB announced that it had arrested two members of a Ukrainian "sabotage group" and two Russian accomplices who were plotting to bomb power lines connected to the Leningrad and Kalinin Nuclear Power Plants, adding that 36.5 kilos of explosives and about 60 detonators were recovered from them. The Russian Defence Ministry said it had scrambled Su-27 and Su-35 fighter jets to intercept two US Air Force B-1B strategic bombers near the country's airspace boundary over the Baltic Sea.
=== Scoring system === Correlated with clinical findings, a white blood cell count greater than 15,000 cells/mm3 and serum sodium level less than 135 mmol/L are predictive of necrotizing fasciitis in 90% of cases. If lab values do not meet those values, there is a 99% chance that the patient does not have NF. There are various scoring systems to determine the likelihood of getting necrotizing fasciitis. The laboratory risk indicator for necrotizing fasciitis (LRINEC) scoring system developed by Wong and their colleagues in 2004 is the most common. It evaluates people with severe cellulitis or abscesses to determine the likelihood of necrotizing fasciitis. LRINEC uses six laboratory values: C-reactive protein, total white blood cell count, hemoglobin, sodium, creatinine, and blood glucose. A score of 6 or more indicates that there is a 50–75% probability of necrotizing fasciitis. A score of 8 or more represents over 75% likelihood of NF. Patients with a LRINEC score ≥6 may have a higher rate of both death and amputation as well. The scoring criteria are:
=== Army service === In the U.S. Army, Jones took part in World War I in an all-Black unit until his mechanical skills were spotted, and he was promoted to sergeant working as an electrician and even teaching other soldiers. Jones performed the wiring necessary to equip his camp with electricity, telegraph, and telephone services.
President Benjamin Asher (Aaron Eckhart) from being killed. The film was a commercial success; however, writing for The A.V. Club, Ignatiy Vishnevetsky criticized the cheap filmmaking, saying: "The movie periodically cuts to overqualified supporting actors—including Freeman, Melissa Leo, and Robert Forster ... (As it turns out, it's possible to write something that will sound like garbage even when spoken in Freeman's sonorous voice.)" Next, Freeman reprised his role as Thaddeus Bradley, starring in Now You See Me 2 (2016), the sequel to Now You See Me, the sequel grossing a successful $334.9 million worldwide. Finally, he had a leading role in the historical drama Ben-Hur, the fifth film adaptation of the 1880 novel Ben-Hur: A Tale of the Christ by Lew Wallace. Freeman expressed interest in playing Sheik Ilderim, a wealthy Nubian sheik, stating: "This character has quite a bit of power in the story. And I like playing power. It's something about my own personal ego." Ben-Hur turned out to be one of 2016's biggest box-office bombs.
Sources: en.wikipedia.org
=== Legal status === The US Food and Drug Administration (FDA) granted the application for tirzepatide priority review designation. Mounjaro was approved for medical use in the US in 2022. In July 2022, the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion, recommending granting a marketing authorization for the medicinal product Mounjaro, intended for the treatment of type 2 diabetes. Tirzepatide was approved for medical use in the European Union in September 2022. In December 2024, the FDA approved tirzepatide (Zepbound) as the first medication to be used in the treatment of moderate to severe obstructive sleep apnea. The FDA granted the application for tirzepatide (Zepbound) fast track, priority review, and breakthrough therapy designations for the treatment of moderate to severe obstructive sleep apnea. The FDA granted the approval of Zepbound to Eli Lilly. Tirzepatide was approved for treatment of type 2 diabetes in the US in May 2022, in the European Union in September 2022, in Canada in November 2022, and in Australia in December 2022. The US Food and Drug Administration (FDA) considers it a first-in-class medication. The FDA approved it for weight loss in November 2023. Also in November 2023, the UK Medicines and Healthcare products Regulatory Agency revised the indication for tirzepatide (as Mounjaro) to include weight management and weight loss. In December 2024, the FDA revised the indication for tirzepatide (as Zepbound) to include the treatment of moderate-to-severe obstructive sleep apnea.
Menthol's ability to chemically trigger the cold-sensitive TRPM8 receptors in the skin is responsible for the well-known cooling sensation it provokes when inhaled, eaten, or applied to the skin. In this sense, it is similar to capsaicin, the chemical responsible for the spiciness of hot chilis (which stimulates heat sensors, also without causing an actual change in temperature). Menthol's analgesic properties are mediated through a selective activation of κ-opioid receptors. Menthol blocks calcium channels and voltage-sensitive sodium channels, reducing neural activity that may stimulate muscles. Some studies show that menthol acts as a GABAA receptor positive allosteric modulator and increases GABAergic transmission in PAG neurons. Menthol has anesthetic properties similar to, though less potent than, propofol because it interacts with the same sites on the GABAA receptor. Menthol may also enhance the activity of glycine receptors and negatively modulate 5-HT3 receptors and nAChRs. Menthol is widely used in dental care as a topical antibacterial agent, effective against several types of streptococci and lactobacilli. Menthol also lowers blood pressure and antagonizes vasoconstriction through TRPM8 activation. Menthol inhalation was demonstrated to improve cognitive decline in Alzheimer's disease mouse models. It also produced immunostimulatory effects in the mice.
=== Clinical trials === A phase II study was conducted comparing the safety and efficacy of omadacycline to linezolid for the treatment of complicated skin and skin structure infections. Patients were randomized at 11 sites in the US to receive either omadacycline 100 mg intravenously once daily with an option to transition to 200 mg orally once daily or linezolid 600 mg intravenously twice daily with an option to transition to 600 mg orally twice daily. The results indicated that omadacycline is well tolerated and has the potential to be an effective treatment in patients with complicated skin and skin structure infections. In June 2013, the US Food and Drug Administration (FDA) designated the intravenous and oral formulations of omadacycline as a qualified infectious disease product in the treatment of acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia. A 650-patient phase III registration study comparing omadacycline to linezolid for the treatment of acute bacterial skin and skin structure infections began in June 2015. Omadacycline met the primary efficacy endpoint of early clinical response with statistical non-inferiority (10% margin) compared to linezolid, and was generally safe and well tolerated. The most common treatment-emergent adverse events were gastrointestinal side effects (18.0% for omadacycline vs. 15.8% for linezolid). A 750-patient phase III study comparing omadacycline to moxifloxacin for the treatment of community-acquired bacterial pneumonia began in November 2015.
One of the earliest techniques used to preserve flowers is air drying. Many plant species are capable of retaining their general shape and coloration when left to dry naturally in ambient conditions. Another method involves the use of glycerine, which helps maintain the flexibility and longevity of the preserved plant material. For effective preservation, the plant is fully hydrated before treatment. A solution is prepared using a mixture of lukewarm water and glycerine, typically in a 2:1 ratio. The use of warm water aids in dissolving the glycerine and enhances absorption. However, this technique is not effective when foliage has already begun to display autumnal coloration. Pressing is a widely used method that results in flattened specimens, often used for botanical studies or decorative purposes. This process is also known as Oshibana. The process typically involves placing flowers between sheets of unglazed paper, such as newsprint or pages from a telephone book, ensuring that individual specimens do not overlap. Multiple layers are often stacked and pressed under a flat, heavy object. The drying period varies depending on the species and moisture content but generally ranges from two to four weeks.
Emergency locator beacon – a portable battery powered radio transmitter used in emergencies to locate airplanes, vessels, and persons in distress and in need of immediate rescue. Various types of emergency locator beacons are carried by aircraft, ships, vehicles, hikers and cross-country skiers. In the event of an emergency, such as the aircraft crashing, the ship sinking, or a hiker becoming lost, the transmitter is deployed and begins to transmit a continuous radio signal, which is used by search and rescue teams to quickly find the emergency and render aid. The latest generation Emergency Position Indicating Rescue Beacons (EPIRBs) contain a GPS receiver, and broadcast to rescue teams their exact location within 20 meters. Cospas-Sarsat – an international humanitarian consortium of governmental and private agencies which acts as a dispatcher for search and rescue operations. It operates a network of around 65 satellites carrying radio receivers, which detect distress signals from emergency locator beacons anywhere on Earth transmitting on the international Cospas distress frequency of 406 MHz. The satellites calculate the geographic location of the beacon within 2 km by measuring the Doppler frequency shift of the radio waves due to the relative motion of the transmitter and the satellite, and quickly transmit the information to the appropriate local first responder organizations, which perform the search and rescue.
Sources: en.wikipedia.org
Semax is based on the ACTH(4-10) fragment, a seven-amino-acid segment of adrenocorticotropic hormone. The synthetic peptide retains the core sequence while removing regions associated with endocrine activity. This modification is intended to isolate effects on the nervous system.
It is registered for clinical use in Russia and a few other countries, typically as a nasal drop formulation. It does not hold approval from the United States Food and Drug Administration or the European Medicines Agency. Outside those markets it is generally handled as a research chemical.
The compound was developed in Moscow and the earliest studies were conducted there, so the primary literature is largely in Russian-language journals. Translation and indexing have been incomplete, which limits access for outside researchers. Independent groups have since published some work, but the total volume remains modest.
It is a short synthetic peptide built from seven amino acids: methionine, glutamic acid, histidine, phenylalanine and three prolines. The sequence derives from the 4-10 fragment of adrenocorticotropic hormone with an added proline-glycine-proline tail. No plant or animal extract is involved; the material is produced by solid-phase peptide synthesis.